Rheumatology · Pembroke Pines, FL
NPI
1407896558
Since 2006
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
12151 Taft St
Pembroke Pines, FL, 33026
Phone (954) 704-1050
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
49,259 services
Medicare patients, 2024
218
Average age 74
Drug cost, 2024
$1.9M
1,007 prescriptions
Company payments, 2025
$3,296
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose G Garcia was code J0897 (injection, denosumab, 1 mg), 3,840 times for 41 patients. In total Jose G Garcia billed 49,259 services in 46 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,840 | 41 | $20.41 | $78K |
| 97110 PT Treatment | Office | 504 | 22 | $18.85 | $9,500 |
| 96401 Chemotherapy Administration | Office | 395 | 73 | $59.17 | $23K |
| 97535 Occupational Therapy | Office | 287 | 22 | $26.72 | $7,670 |
| 97140 PT Treatment | Office | 286 | 22 | $17.62 | $5,039 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 263 | 148 | $14.00 | $3,682 |
| 99214 Office E&M - Established | Office | 259 | 130 | $102.88 | $27K |
| 97112 PT Treatment | Office | 254 | 21 | $21.40 | $5,437 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 105 | 28 | $0.77 | $80.47 |
| 99213 Office E&M - Established | Office | 99 | 66 | $69.20 | $6,851 |
| 96413 Chemotherapy Administration | Office | 97 | 21 | $107.45 | $10K |
| 36415 Venipuncture Blood Collection | Office | 86 | 53 | $4.90 | $421 |
| 96415 Chemotherapy Administration | Office | 67 | 11 | $23.10 | $1,547 |
| 20610 Joint Injection | Office | 49 | 21 | $49.74 | $2,437 |
| 99204 Office E&M - New | Office | 48 | 48 | $136.06 | $6,531 |
By year: 2022 $400K for 36,846 services; 2023 $356K for 38,668 services; 2024 $485K for 49,259 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 86 | 53 | $4.90 | $421 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose G Garcia prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 105 prescriptions and refills. In total Jose G Garcia wrote 1,007 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 105 | 189 | 33 | $856 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 78 | 78 | 13 | $194K |
| Cimzia (2 Pack) Certolizumab Pegol | 66 | 71 | Under 11 | $421K |
| Prednisone Generic | 56 | 62 | 21 | $155 |
| Diclofenac Sodium Generic | 52 | 60 | 12 | $2,305 |
| Folic Acid Generic | 49 | 86 | 16 | $119 |
| Meloxicam Generic | 41 | 47 | 11 | $91.52 |
| Prolia Denosumab | 37 | 222 | 26 | $66K |
| Rasuvo Methotrexate/Pf | 32 | 32 | Under 11 | $18K |
| Hydroxychloroquine Sulfate Generic | 32 | 58 | Under 11 | $466 |
| Alendronate Sodium Generic | 28 | 50 | Under 11 | $108 |
| Leflunomide Generic | 24 | 56 | Under 11 | $784 |
| Sulfasalazine Generic | 22 | 26 | Under 11 | $426 |
| Orencia Clickject Abatacept | 21 | 21 | Under 11 | $121K |
| Humira(Cf) Pen Adalimumab | 20 | 20 | Under 11 | $136K |
Brand drugs: 409 claims; generic drugs: 598 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose G Garcia $3,296 ($3,296 in general payments such as food, travel and fees) from 23 companies. The largest payer was Amgen Inc. with $460.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.